Biodesix Inc (BDSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 9,056 | 9,607 | 11,107 | 10,950 | 6,548 |
| Cost of Goods | 3,169 | 3,306 | 3,633 | 3,980 | 3,235 |
| Gross Profit | 5,887 | 6,301 | 7,474 | 6,970 | 3,313 |
| Operating Expenses | 22,429 | 20,497 | 18,717 | 19,576 | 18,009 |
| Operating Income | -16,373 | -13,890 | -10,610 | -11,626 | -14,461 |
| Interest Expense | 2,391 | 2,550 | 3,039 | 1,346 | 1,137 |
| Other Income | 62 | -3,898 | -50 | -2,852 | 12 |
| Pre-tax Income | -18,702 | -20,338 | -13,699 | -15,824 | -15,586 |
| Net Income Continuous | -18,702 | -20,338 | -13,699 | -15,824 | -15,586 |
| Net Income | $-18,702 | $-20,338 | $-13,699 | $-15,824 | $-15,586 |
| EPS Basic Total Ops | -4.80 | -6.20 | -6.80 | -8.00 | -10.00 |
| EPS Basic Continuous Ops | -4.81 | -6.22 | -6.77 | -8.07 | -10.03 |
| EPS Diluted Total Ops | -4.80 | -6.20 | -6.80 | -8.00 | -10.00 |
| EPS Diluted Continuous Ops | -4.81 | -6.22 | -6.77 | -8.07 | -10.03 |
| EBITDA(a) | $-13,451 | $-12,218 | $-6,109 | $-9,112 | $-12,186 |